Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT03167255 · COMPLETED
Trial details
- NCT number
- NCT03167255
- Sponsor
- NS Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-06
- Primary completion
- 2021-10-20
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.